secwatch.observer — SEC 8-K summary
======================================

Issuer:     Polomar Health Services, Inc. (PMHS)
CIK:        0001265521
Form:       8-K
Filed at:   2025-03-17T23:59:59+00:00
Accession:  0001493152-25-010634
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Polomar Health signs exclusive distribution deal for inhalable sildenafil and sumatriptan
--------------------------------------------------------------------------------

- Agreement with ForHumanity Health and Island 40 Group grants exclusivity through Sep 30, 2025, in exchange for $750,000 guaranteed revenue.
- ForHumanity made a $250,000 advance payment to secure exclusivity; remaining $500,000 due by June 30, 2025.
- Initial term of 3 years through March 2028; auto-renewal for up to 5-year terms if revenue targets met (minimum $3M average annually for first renewal).
- Exclusivity can be extended through Dec 31, 2028, if ForHumanity achieves escalating revenue milestones (e.g., $20M by 2027).
- Polomar Specialty Pharmacy will fulfill prescriptions; IG4 handles account management.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1265521/000149315225010634/0001493152-25-010634-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1265521/000149315225010634/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-010634

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer